Remove Containment Remove Development Remove Filler Remove Marketing
article thumbnail

Some Talc Products Contain Asbestos: Study

The Pharma Data

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. The voluntary testing method developed by industry is not sensitive enough to screen for asbestos when compared to electron microscopy, the group said. MONDAY, Nov. Food and Drug Administration does not require testing talc supplies.

article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

BONESUPPORT received market authorization from the FDA for Cerament G, the first and only bone graft with antibiotic elution that is approved for the US market. BONESUPPORT has recently received market authorization from the US Food and Drug Administration (FDA) for Cerament G, its bone graft with antibiotic elution.

Filler 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SweetLeaf Xylitol: A New Frontier in Natural Sweetening

XTalks

SweetLeaf Xylitol, the latest innovation from Wisdom Natural Brands, marks a significant development in the natural sweeteners market. SweetLeaf Xylitol is distinct because it contains pure xylitol without any additional fillers or additives, making it a perfect one-to-one substitute for sugar in cooking, baking and beverages.

Filler 52
article thumbnail

Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

The Pharma Data

Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. The specifics will be bared when we conclude specific agreements.

article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

We see the dedication of healthcare workers – or of the shelf-filler in our local store – and we are moved to thank them and to make our own contribution. Kaletra (also known as Aluvia) contains anti-viral components that block virus replication. Something we want to receive and something we want to give. AbbVie has donated $1.5

Branding 101